BioCentury
ARTICLE | Clinical News

Allob: Phase I/IIa data

February 2, 2015 8:00 AM UTC

Data from the first cohort of 4 patients with non-infected, delayed-union fractures of long bones in an open-label, European Phase I/IIa trial showed that a single implantation of Allob into the fract...